Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 3;14(9):e0220908.
doi: 10.1371/journal.pone.0220908. eCollection 2019.

Clinical correlation of influenza and respiratory syncytial virus load measured by digital PCR

Affiliations

Clinical correlation of influenza and respiratory syncytial virus load measured by digital PCR

Diego R Hijano et al. PLoS One. .

Abstract

Acute respiratory tract infections are a major cause of respiratory morbidity and mortality in pediatric patients worldwide. However, accurate viral and immunologic markers to predict clinical outcomes of this patient population are still lacking. Droplet digital PCR assays for influenza and respiratory syncytial virus (RSV) were designed and performed in 64 respiratory samples from 23 patients with influenza virus infection and 73 samples from 19 patients with RSV infection. Samples of patients with hematologic malignancies, solid tumors, or sickle cell disease were included. Clinical information from institutional medical records was reviewed to assess disease severity. Samples from patients with fever or respiratory symptoms had a significantly higher viral loads than those from asymptomatic patients. Samples from patients with influenza virus and RSV infection collected at presentation had significantly higher viral loads than those collected from patients after completing a course of oseltamivir or ribavirin, respectively. RSV loads correlated positively with clinical symptoms in patients ≤5 years of age, whereas influenza viral loads were associated with clinical symptoms, irrespective of age. Patients receiving antivirals for influenza and RSV had a significant reduction in viral loads after completing therapy. Digital PCR offers an effective method to monitor the efficacy of antiviral treatment for respiratory tract infections in immunocompromised hosts.

PubMed Disclaimer

Conflict of interest statement

Randall T. Hayden has served on the advisory boards for Roche Molecular, Abbott Molecular, and Quidel. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Correlation of influenza virus and RSV viral loads with clinical infection.
Viral load and presence of fever, cough, and/or nasal congestion for (A) influenza virus A, (B) influenza virus B, and (C) RSV. Viral load and presence of 1–3 symptoms for patients with (D) influenza A, (E) influenza B, and (F) RSV infection. P values from mixed linear regression model *P < 0.05; **P < 0.01; ***P < 0.001. yo, years old; viral loads (log10 copies/ml). Dotted line represents lower limit of quantification for each assay.
Fig 2
Fig 2. Correlation of influenza viral load with clinical signs/symptoms.
Influenza A viral load and presence of (A) fever, (B) cough, and/or (C) nasal congestion. Influenza B viral load and presence of (D) fever, (E) cough, and/or (F) nasal congestion. RSV viral load and presence of (G) fever, (H) cough, and/or (I) nasal congestion. P values from mixed linear regression model *P < 0.05; **P < 0.01; ***P < 0.001. Viral loads (log10 copies/ml). Dotted line represents lower limit of quantification for each assay.
Fig 3
Fig 3. Correlation of lymphopenia with viral load and clinical symptoms.
Correlation between ALC and (A) influenza A viral load, (C) influenza B viral load, and (E) RSV viral load (E). ALCs and the presence of clinical symptoms for (B) influenza A, (D) influenza B, and (F) RSV. P values from mixed linear regression model *P < 0.05; **P < 0.01; ***P < 0.001. Viral loads (log10 copies/ml).
Fig 4
Fig 4. Influenza and RSV viral loads after antiviral treatment.
Influenza viral load before and after oseltamivir treatment for (A) influenza A and (B) influenza B. (C) RSV viral load before and after ribavirin treatment. *P < 0.05; **P < 0.01; ***P < 0.001. Viral loads (log10 copies/ml); Dotted line represents lower limit of quantification for each assay.

References

    1. Rudan I, O'Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. Journal of global health. 2013;3(1):010401 Epub 2013/07/05. 10.7189/jogh.03.010401 - DOI - PMC - PubMed
    1. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. The American journal of medicine. 1997;102(3a):10–8; discussion 25–6. Epub 1997/03/17. 10.1016/s0002-9343(97)80004-6 . - DOI - PMC - PubMed
    1. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents [accessed 2016 July 2]. Available from: http://aidsinfo.nih.gov/guidelines.
    1. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (London, England). 2010;375(9725):1545–55. Epub 2010/04/20. 10.1016/s0140-6736(10)60206-1 - DOI - PMC - PubMed
    1. DeVincenzo JP, Buckingham SC. Relationship between respiratory syncytial virus load and illness severity in children. The Journal of infectious diseases. 2002;186(9):1376–7; author reply 7. Epub 2002/10/29. 10.1086/344331 . - DOI - PubMed

Publication types

MeSH terms

Substances